Our cardiologists are at the cutting edge of their fields of interest. They are active researchers and are asked to lecture locally and internationally. See below for a selection of their research:
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
Circulation. 2018 Oct 23;138(17):1780-1792. doi: 10.1161/CIRCULATIONAHA.118.033801.
Regression of left ventricular hypertrophy provides an additive physiological benefit following treatment of aortic stenosis: Insights from serial coronary wave intensity analysis.
Acta Physiol (Oxf). 2018 Dec;224(4):e13109. doi: 10.1111/apha.13109. Epub 2018 Aug 3.
Outcomes after chronic total occlusion percutaneous coronary interventions: an observational study of 5496 patients from the Pan-London CTO Cohort.
Coron Artery Dis. 2018 Nov;29(7):557-563. doi: 10.1097/MCA.0000000000000644.
Use of the reported Edmonton frail scale in the assessment of patients for transcatheter aortic valve replacement: a possible selection tool in very high-risk patients?
J Geriatr Cardiol. 2018 Jun;15(6):463-466. doi: 10.11909/j.issn.1671-5411.2018.06.010.
Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease.
J Am Coll Cardiol. 2018 Aug 28;72(9):970-983. doi: 10.1016/j.jacc.2018.06.033.
Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.
J Am Coll Cardiol. 2018 Oct 23;72(17):1989-1999. doi: 10.1016/j.jacc.2018.07.089.